We are committed to improving the lives of patients

Kadmon offers a portfolio of products for the treatment of serious and rare diseases.

CLOVIQUE™ (Trientine Hydrochloride Capsules, USP) Blister Pack trientine hydrochloride capsules, USP

Trientine Hydrochloride Capsules, USP trientine hydrochloride capsules, USP

Capecitabine Tablets, USP capecitabine tablets, USP

Entecavir Tablets entecavir tablets

Temozolomide Capsules temozolomide capsules

Tetrabenazine Tablets tetrabenazine tablets

Tobramycin Inhalation Solution, USP tobramycin Inhalation solution, USP

Medical Information
For product inquiries or to report an adverse event or product quality complaint for a Kadmon marketed product, please call 1.877.377.7862. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1.800.FDA.1088.

Consumer Product Safety Improvement Act (CPSIA) Certification
In accordance with the CPSIA of 2008, Kadmon certifies that our product’s child-resistant packaging comply with the standards established under the Poison Prevention Packaging Act of 1970 as amended. To receive a copy of a CPSIA certificate for a Kadmon product, please contact Medical Information at 1.877.377.7862 or